Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Contactin associated protein-like 3B pseudogene (CNTNAP3B pseudogene)
- Target
- CNTNAP3B pseudogene
- Molecular classification
- Other (pseudogene; derived from a cell adhesion molecule family member but lacks protein-coding ability)
01
Overview
Contactin associated protein-like 3B pseudogene (CNTNAP3B pseudogene) is a noncoding genomic element similar in sequence to the parent protein-coding gene CNTNAP3B, which is itself a member of the contactin-associated protein family involved in cell adhesion[1][2]. As a pseudogene, this locus does not produce a functional protein, but may exert regulatory effects via its RNA through mechanisms such as microRNA competition, lncRNA formation, or modulation of its parental gene expression through molecular decoys or RNA-binding protein interactions[3][7]. Pseudogenes may have subtle regulatory roles in disease pathogenesis, but CNTNAP3B pseudogene is not presently recognized as a drug target, disease marker, or receptor. No drugs are known to interact directly with it, and there is no specific mechanism or safety challenge described in the literature for this target[2][3].
- Other names
- Contactin associated protein-like 3B pseudogeneCNTNAP3B pseudogeneLOC101930090Contactin-associated protein-like 3B pseudogene
02
Mechanism of action
Not applicable for drugs, since it is not a therapeutic target.
03
Biological functions
Regulatory RNA function: may modulate expression of its parental gene (CNTNAP3B) or other genes via mechanisms such as competing for microRNAs (miRNA) or interacting with RNA-binding proteins (RBPs)May act as a competitive endogenous RNA (ceRNA) or generate noncoding RNAs (such as lncRNAs)No direct protein-coding or receptor functions
04
Disease associations
Possible indirect roles in disease through regulatory effects; direct evidence is limited for this specific pseudogene, but similar pseudogenes have been implicated in cancer, neurodegeneration, and cardiovascular diseaseNot established as a direct marker or therapeutic target in any disease context
05
Safety considerations
None specific; as a pseudogene lacking protein-coding function, there are no direct safety concerns associated with targeting this locus. Theoretical considerations about pseudogene-derived RNA as regulatory factors exist
06
Biomarkers
No established utility as a biomarkerThe role of pseudogenes as noncoding RNA biomarkers is emerging but not established for this target.
Beyond the preview
Go deeper on Contactin associated protein-like 3B pseudogene (CNTNAP3B pseudogene).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Contactin associated protein-like 3B pseudogene (CNTNAP3B pseudogene).